Immunohistochemistry with Mutation Specific Antibodies Detecting the Status of EGFR Mutations in Non-Small-Cell Lung Cancer

被引：0
|
作者：
Li, D.
Chen, S.
Hu, C.
Lei, Y.
Yu, J.
机构：
[1] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[2] Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[3] Hunan Prov Peoples Hosp, Changsha, Hunan, Peoples R China
[4] Cell Signaling Technol, Danvers, MA USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1818
引用
收藏
页码：407A / 407A
页数：1
相关论文
共 50 条
  • [21] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
  • [22] Intratumor heterogeneity of non-small-cell lung cancer with EGFR mutations
    Qiao, Sitan
    Zhao, Xin
    Zhou, Xinlan
    Zhang, Yaxiong
    Zhang, Li
    Wu, Kui
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [23] Classification of atypical EGFR mutations in non-small-cell lung cancer
    Rosell, R.
    Cardona, A. F.
    Arrieta, O.
    Gonzalez-Cao, M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (06) : 571 - 573
  • [24] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [25] The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer
    Jingya Zhao
    Xiaoying Wang
    Liang Xue
    Nuo Xu
    Xin Ye
    Haiying Zeng
    Shaohua Lu
    Jie Huang
    Sujie Akesu
    Chen Xu
    Deming He
    Yunshan Tan
    Qunying Hong
    Qun Wang
    Guanshan Zhu
    Yingyong Hou
    Xin Zhang
    [J]. Journal of Cancer Research and Clinical Oncology, 2014, 140 : 849 - 857
  • [26] The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer
    Zhao, Jingya
    Wang, Xiaoying
    Xue, Liang
    Xu, Nuo
    Ye, Xin
    Zeng, Haiying
    Lu, Shaohua
    Huang, Jie
    Akesu, Sujie
    Xu, Chen
    He, Deming
    Tan, Yunshan
    Hong, Qunying
    Wang, Qun
    Zhu, Guanshan
    Hou, Yingyong
    Zhang, Xin
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (05) : 849 - 857
  • [27] Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
    Rosell, Rafael
    Aguilar-Hernandez, Andres
    Gonzalez-Cao, Maria
    [J]. CANCERS, 2023, 15 (09)
  • [28] The impact of EGFR mutation and smoking status on non-small-cell lung cancer patients treated with geftinib
    Toyooka, Shinichi
    Takano, Toshimi
    Kosaka, Takayuki
    Ichihara, Shuji
    Fujiwara, Yoshiro
    Hotta, Katsuyuki
    Soh, Junichi
    Kiura, Katsuyuki
    Yatabe, Yasushi
    Ohe, Yuichiro
    Mitsudomi, Tetsuya
    Date, Hiroshi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S324 - S324
  • [29] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    [J]. BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
  • [30] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
    Fang, Shu
    Wang, Zhehai
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611
12345